| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.4B | $7.6B | $8.4B | $6.8B | $5.4B | $1.3B | $1.3B | $1.0B |
| Cost of Revenue | $1.9B | $2.6B | $2.7B | $2.4B | $2.1B | $2.0B | $2.4B | — |
| Gross Profit | $2.5B | $5.0B | $5.7B | $4.4B | $3.4B | $0.8B | $0.8B | $0.6B |
| R&D Expense | $1.0B | $1.1B | $1.1B | $1.0B | $0.8B | $0.9B | $0.8B | $0.5B |
| SG&A Expense | $0.6B | $0.7B | $0.8B | $0.7B | $0.6B | $0.7B | $0.7B | $0.5B |
| Operating Income | $0.3B | $2.6B | $3.1B | $1.8B | $1.0B | $0.2B | $0.3B | $0.2B |
| Net Income | $-0.0B | $1.9B | $2.2B | $1.3B | $0.3B | $0.1B | $0.4B | $0.3B |
| EPS (Basic) | $-0.01 | $3.52 | $4.07 | $2.33 | $1.35 | $2.39 | $1.51 | $1.10 |
| EPS (Diluted) | $-0.01 | $3.48 | $4.02 | $2.27 | $1.29 | $0.39 | $0.70 | $0.58 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $15.4B | $15.9B | $16.4B | $16.2B | $16.5B | $17.4B | $18.4B | $8.3B |
| Current Assets | $3.0B | $3.0B | $3.1B | $2.5B | $2.1B | $2.2B | $2.2B | $3.4B |
| Cash & Equivalents | $0.8B | $0.3B | $0.2B | $0.3B | $0.3B | $0.4B | $0.4B | $0.9B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.2B | $2.5B | $3.1B | $1.4B | $2.4B | $1.6B | $2.4B | $2.0B |
| Stockholders' Equity | $7.1B | $6.7B | $6.5B | $5.9B | $5.3B | $5.6B | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.9B | $2.9B | $3.6B | $2.8B | $1.9B | $1.5B | — | — |
| Investing Cash Flow | $-0.3B | $-0.4B | $-0.6B | $-0.5B | $-0.2B | $-0.1B | $-6.8B | $-1.0B |
| Capital Expenditures | $0.1B | $0.3B | $0.5B | $0.4B | $0.1B | $0.1B | — | — |
| Financing Cash Flow | $-0.2B | $-2.4B | $-3.1B | $-2.3B | $-1.9B | $-1.4B | $4.7B | $-0.4B |